https://scholarship.law.cornell.edu/cgi/viewcontent.cgi?arti...
It basically boils down to surgical training/procedural variance across geographic regions that make it hard to extrapolate some conclusions without multi centered trials, surgeon hubris, and self-regulation through way of surgical societies sponsoring trials and publishing guidelines. I think many also overestimate the FDAs ability to regulate "useless" medicine, so doctors that prescribe medicine also have the same problems surgeons do.
The article goes over more of this as well, but there's some regulation just not by a federal agency (unless you count CMS compensation/approval). Maybe we'll eventually have a group that specifically monitors surgical procedures.
Finally, I think it's fairly telling that the majority of these "useless" surgeries are elective procedures
(disclosure, if it matters: I'll be entering a surgical field that almost exclusively only performs elective procedures)
Multiple facilities sharing a common head surgeon, or the same facility after the arrival or departure of a surgeon being strongly detectable in outcomes data, from what I've heard.
Placebo-controlled trials for surgeries, as there already is for drugs, could do the trick.
For surgeries ? We actually cut someone open, then don't fix him, risking all the complications associated with anesthesia, infections and so on ? For drugs it's pretty easy to just give a fake pill containing nothing at all, you don't actually decrease then chance of survival.
And how does that work when the technique significantly changes, as in "in that case, do we cut above or below the knee". Again in the case of pills/injections, it's pretty easy to give everyone the impression they got all the same treatment, while in the of surgery you are pretty limited in that fashion.
Yes. There have been placebo-controlled trials whereby the control-group was just cut open, and left there for an hour. The placebo-patients believed they had undergone the actual procedure, and reported the same improvement as the actual patients. This is the placebo effect.
Although such trials are harder than giving fake pills, they might still be worthy of doing more often than we do now.
Placebo surgery trials would also benefit humanity a lot in better focused efforts, money and saving future patients from having to undergo useless surgery and take risks.
Somehow you imply it's ethical to try and fix a patient with a potentially sham surgery and risk complications, but it's unethical to do it with placebo thereby gaining knowledge that can save lots of lives down the line.
I guess it's a kind of trolley problem but have those been "solved"? Who decides if it's ethical or not? Why are they qualified to make such a decision?
Some of those are only guidance and NHS Trusts (the organisations that provide care) and CCGs (the organisations that take money from government and buy care from provider organisations) only have to consider it.
But some of them are mandatory and CCGs and trusts must follow it, unless they have very good reason not to.
Here's their guidance for "Arthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis
Interventional procedures guidance [IPG230] Published date: 22 August 2007"
https://www.nice.org.uk/guidance/ipg230
And if people really want something that's been recommended against by NICE they can go private, I guess.
But heavily regulating drugs, while surgeries that could have severe risks, complications, or have no proven effect in placebo-controlled trials, go mostly unregulated, strikes me as odd.